(Q44348371)

English

A randomized clinical trial of adjuvant chemotherapy with doxorubicin, ifosfamide, and cisplatin followed by radiotherapy versus radiotherapy alone in patients with localized uterine sarcomas (SARCGYN study). A study of the French Sarcoma Group

scientific article published on 8 November 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

2 December 2017

A randomized clinical trial of adjuvant chemotherapy with doxorubicin, ifosfamide, and cisplatin followed by radiotherapy versus radiotherapy alone in patients with localized uterine sarcomas (SARCGYN study). A study of the French Sarcoma Group (English)

1 reference

Europe PubMed Central

2 December 2017

radiation therapy

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Isabelle Ray-Coquard

5

object named as

I Ray-Coquard

1 reference

Europe PubMed Central

2 December 2017

author name string

P Pautier

1

1 reference

Europe PubMed Central

2 December 2017

A Floquet

2

1 reference

Europe PubMed Central

2 December 2017

L Gladieff

3

1 reference

Europe PubMed Central

2 December 2017

E Bompas

4

1 reference

Europe PubMed Central

2 December 2017

S Piperno-Neumann

6

1 reference

Europe PubMed Central

2 December 2017

F Selle

7

1 reference

Europe PubMed Central

2 December 2017

C Guillemet

8

1 reference

Europe PubMed Central

2 December 2017

B Weber

9

1 reference

Europe PubMed Central

2 December 2017

R Largillier

10

1 reference

Europe PubMed Central

2 December 2017

F Bertucci

11

1 reference

Europe PubMed Central

2 December 2017

P Opinel

12

1 reference

Europe PubMed Central

2 December 2017

F Duffaud

13

1 reference

Europe PubMed Central

2 December 2017

A Reynaud-Bougnoux

14

1 reference

Europe PubMed Central

2 December 2017

C Delcambre

15

1 reference

Europe PubMed Central

2 December 2017

N Isambert

16

1 reference

Europe PubMed Central

2 December 2017

P Kerbrat

17

1 reference

Europe PubMed Central

2 December 2017

G Netter-Pinon

18

1 reference

Europe PubMed Central

2 December 2017

N Pinto

19

1 reference

Europe PubMed Central

2 December 2017

P Duvillard

20

1 reference

Europe PubMed Central

2 December 2017

C Haie-Meder

21

1 reference

Europe PubMed Central

2 December 2017

C Lhommé

22

1 reference

Europe PubMed Central

2 December 2017

A Rey

23

1 reference

Europe PubMed Central

2 December 2017

publication date

8 November 2012

1 reference

Europe PubMed Central

2 December 2017

Annals of Oncology

1 reference

Europe PubMed Central

2 December 2017

24

1 reference

Europe PubMed Central

2 December 2017

4

1 reference

Europe PubMed Central

2 December 2017

1099-1104

1 reference

Europe PubMed Central

2 December 2017

Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: an European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874).

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS545

21 January 2018

Adjuvant chemotherapy with cisplatin, ifosfamide, and doxorubicin followed by radiotherapy in localized uterine sarcomas: results of a case-control study with radiotherapy alone.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS545

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS545

21 January 2018

Effect of adjuvant chemotherapy on survival in FNCLCC grade 3 soft tissue sarcomas: a multivariate analysis of the French Sarcoma Group Database

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS545

21 January 2018

A randomized study of adriamycin with and without dimethyl triazenoimidazole carboxamide in advanced uterine sarcomas

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS545

21 January 2018

High-dose doxorubicin infusion therapy for disseminated mixed mesodermal sarcoma of the uterus

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS545

21 January 2018

Phase II trial of ifosfamide and mesna in leiomyosarcoma of the uterus: a Gynecologic Oncology Group study

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS545

21 January 2018

Phase II trial of ifosfamide and mesna in mixed mesodermal tumors of the uterus (a Gynecologic Oncology Group study).

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS545

21 January 2018

Cyclophosphamide, vincristine, adriamycin, and dimethyl-triazeno imidazole carboxamide (CYVADIC) for sarcomas of the female genital tract

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS545

21 January 2018

Gemcitabine and docetaxel in patients with unresectable leiomyosarcoma: results of a phase II trial.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS545

21 January 2018

Cisplatin-based chemotherapy regimen (DECAV) for uterine sarcomas.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS545

21 January 2018

High-dose ifosfamide: circumvention of resistance to standard-dose ifosfamide in advanced soft tissue sarcomas

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS545

21 January 2018

Prognostic factors for the outcome of chemotherapy in advanced soft tissue sarcoma: an analysis of 2,185 patients treated with anthracycline-containing first-line regimens--a European Organization for Research and Treatment of Cancer Soft Tissue and

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS545

21 January 2018

Adjuvant vincristine, dactinomycin, and cyclophosphamide therapy in stage I uterine sarcomas. A pilot study

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS545

21 January 2018

Adjuvant gemcitabine plus docetaxel for completely resected stages I-IV high grade uterine leiomyosarcoma: Results of a prospective study

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS545

21 January 2018

Identifiers

10.1093/ANNONC/MDS545

1 reference

Europe PubMed Central

2 December 2017

1 reference

Europe PubMed Central

2 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44348371&oldid=2109628875"